Guardant Health (GH) Other Non-Current Liabilities (2018 - 2026)
Guardant Health (GH) posted Other Non-Current Liabilities of $126.9 million for Q2 2026, down 0.59% sequentially from $127.7 million in Q1 2026, and up 39.24% YoY from $91.2 million in Q2 2025.
Guardant Health (GH) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Guardant Health has reported Other Non-Current Liabilities for 9 years, with the latest figure at $126.9 million in Q2 2026.
- Quarterly Other Non-Current Liabilities rose 39.24% year-over-year to $126.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $126.9 million (up 39.24% YoY) and the FY2025 annual result came in at $127.8 million, up 37.64% from the prior year.
- Other Non-Current Liabilities slipped to $126.9 million in Q2 2026 per GH's latest filing, from $127.7 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $127.8 million in Q4 2025 and troughed at $6.9 million in Q1 2022.
- A 5-year average of $66.3 million and a median of $91.9 million in 2025 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities soared 959.39% in 2024, then fell 4.97% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $9.2 million in 2022, then surged by 945.93% to $96.0 million in 2023, then fell by 3.3% to $92.8 million in 2024, then soared by 37.64% to $127.8 million in 2025, then dropped by 0.65% to $126.9 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $126.9 million, $127.7 million, and $127.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Guardant Health | 22.38 Bn | 21.33 Bn | 219.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 126.94 Mn |
| Mar 31, 2026 | 127.69 Mn |
| Dec 31, 2025 | 127.77 Mn |
| Sep 30, 2025 | 94.36 Mn |
| Jun 30, 2025 | 91.17 Mn |
| Mar 31, 2025 | 92.55 Mn |
| Dec 31, 2024 | 92.83 Mn |
| Sep 30, 2024 | 89.45 Mn |
| Jun 30, 2024 | 95.93 Mn |
| Mar 31, 2024 | 96.79 Mn |
| Dec 31, 2023 | 96.01 Mn |
| Sep 30, 2023 | 10.18 Mn |
| Jun 30, 2023 | 9.45 Mn |
| Mar 31, 2023 | 9.14 Mn |
| Dec 31, 2022 | 9.18 Mn |
| Sep 30, 2022 | 6.99 Mn |
| Jun 30, 2022 | 9.29 Mn |
| Mar 31, 2022 | 6.91 Mn |
| Dec 31, 2021 | 3.93 Mn |
| Sep 30, 2021 | 3.42 Mn |